• Citer

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial

par Opal, Steven;Fisher Jr., Charles;Dhainaut, Jean-Francois;Vincent, Jean Louis ;Brase, Rainer;Lowry, Stephen F.;Sadoff, Jerald;Slotman, Gus;Levy, Howard;Balk, Robert;Shelly, Maire;Pribble, John;LaBrecque, John;Lookabaugh, Janice;Donovan, Hugh;Dubin, Howard;Baughman, Robert;Norman, James;DeMaria, Eric;Matzel, Klaus;Abraham, Edward;Seneff, Michael
Référence Critical care medicine, 25, 7, page (1115-1124)
Publication Publié, 1997-07

Article révisé par les pairs

• Détails

Titre:	Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial
Auteur:	Opal, Steven; Fisher Jr., Charles; Dhainaut, Jean-Francois; Vincent, Jean Louis; Brase, Rainer; Lowry, Stephen F.; Sadoff, Jerald; Slotman, Gus; Levy, Howard; Balk, Robert; Shelly, Maire; Pribble, John; LaBrecque, John; Lookabaugh, Janice; Donovan, Hugh; Dubin, Howard; Baughman, Robert; Norman, James; DeMaria, Eric; Matzel, Klaus; Abraham, Edward; Seneff, Michael
Informations sur la publication:	Critical care medicine, 25, 7, page (1115-1124)
Statut de publication:	Publié, 1997-07
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Cytokines
	Interleukin-1
	Interleukin-1 receptor antagonist
	Sepsis
	Septic shock
Note générale:	SCOPUS: re.j
Langue:	Anglais
Identificateurs:	urn:issn:0090-3493
	info:doi/10.1097/00003246-199707000-00010
	info:scp/0030877935